FIELD: medicine.
SUBSTANCE: remote irradiation, intraluminal brachytherapy, chemotherapy with a drug from the group of fluoropyrimidines are performed. 2-4 hours before the first four fractions of brachytherapy, a drug from the group of fluoropyrimidines is administered intravenously dropwise in a therapeutic dose, in addition, 1-1.5 hours before each brachytherapy session, 20-50 ml of Mildronate solution is injected rectally, and 30-40 minutes after its completion, 5-10 ml of Mildronate is administered intravenously.
EFFECT: method allows to increase the efficiency of combined chemoradiation treatment.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING LOW-LYING TUMORS OF RECTUM AND ANAL CANAL | 2017 |
|
RU2666694C1 |
METHOD OF TREATING SQUAMOUS CELL CANCER OF ANAL CANAL | 2011 |
|
RU2459644C1 |
METHOD OF TREATING RECTAL CANCER | 2018 |
|
RU2691345C1 |
METHOD OF TREATING RECTAL CANCER | 2015 |
|
RU2586042C1 |
METHOD OF TREATING RECTAL CANCER | 2010 |
|
RU2424013C1 |
METHOD OF TREATING ADENOGENOUS LOCALLY ADVANCED CANCER OF LOWER AMPULLARY PART OF RECTUM | 2013 |
|
RU2547999C1 |
METHOD OF CHEMORADIATION THERAPY OF LOW-LOCATED TUMOURS OF RECTUM AND ANAL CANAL | 2009 |
|
RU2400268C1 |
METHOD FOR TREATMENT OF ANAL CANCER WITH SKIN TRANSITION | 2016 |
|
RU2638616C1 |
METHOD OF TREATMENT OF UNRESECTABLE PANCREATICODUODENAL CANCER | 2007 |
|
RU2341308C1 |
METHOD OF TREATING LOCALLY ADVANCED UNRESECTABLE OESOPHAGEAL CANCER | 2011 |
|
RU2468836C1 |
Authors
Dates
2017-08-30—Published
2016-09-28—Filed